Arcus Biosciences General Counsel Carolyn Tang Exercises 34,090 Stock Options

This Form 4 filing reports that Carolyn C. Tang, General Counsel of Arcus Biosciences, exercised 34,090 stock options on June 11, 2026. The options had an exercise price of $2.574 per share and were fully vested. Following the exercise, Tang acquired 34,090 shares of common stock, bringing her total direct holdings to 184,607 shares. The filing notes that 1,783 of these shares were purchased through the company's Employee Stock Purchase Plan on May 31, 2026, and includes unvested restricted stock units. The options were completely exercised and are now at zero balance. This transaction represents a routine insider stock option exercise by a corporate officer.